Severe myasthenia gravis with anti-LRP4 antibodies and Hodgkin lymphoma

被引：1
作者：
Hayashi, Naoki [1 ]
Sone, Jun [2 ]
Fukami, Yuki [1 ]
Yoshida, Yusuke [1 ]
Kuno, Shunsuke [3 ]
Shimada, Kazuyuki [3 ]
Atsuta, Naoki [1 ]
Nakamura, Tomohiko [1 ]
Higuchi, Osamu [4 ]
Katsuno, Masahisa [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi, Japan
[2] Natl Hosp Org Suzuka Natl Hosp, Dept Neurol, Suzuka, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[4] Nagasaki Kawatana Med Ctr, Dept Clin Res, Nagasaki, Japan
来源：
MUSCLE & NERVE | 2021年 / 63卷 / 01期
关键词：
PROTEIN; 4; AUTOANTIBODIES;
D O I：
10.1002/mus.27079
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E2 / E4
页数：4
相关论文
共 43 条
  • [21] A Patient with Fulminant Myasthenia Gravis Is Seropositive for Both AChR and LRP4 Antibodies, Complicated by Autoimmune Polyglandular Syndrome Type 3
    Inoue, Hiroyasu
    Yamada, Kentaro
    Fujii, Asami
    Tomonari, Tatsuya
    Mizuno, Kotaro
    Mita, Keiko
    Higuchi, Osamu
    Akao, Masaya
    Matsukawa, Noriyuki
    INTERNAL MEDICINE, 2020, 59 (17) : 2177 - 2181
  • [22] Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies
    Suzuki, S.
    Baba, A.
    Kaida, K.
    Utsugisawa, K.
    Kita, Y.
    Tsugawa, J.
    Ogawa, G.
    Nagane, Y.
    Kuwana, M.
    Suzuki, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (02) : 223 - 230
  • [23] Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies
    Cenacchi, Giovanna
    Valentina, Papa
    Marina, Fanin
    Elena, Pegoraro
    Corrado, Angelini
    JOURNAL OF NEUROLOGY, 2011, 258 (05) : 746 - 752
  • [24] Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders
    Ohno, Kinji
    Ohkawara, Bisei
    Ito, Mikako
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (10) : 949 - 958
  • [25] MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
    Huijbers, Maartje G.
    Zhang, Wei
    Klooster, Rinse
    Niks, Erik H.
    Friese, Matthew B.
    Straasheijm, Kirsten R.
    Thijssen, Peter E.
    Vrolijk, Hans
    Plomp, Jaap J.
    Vogels, Pauline
    Losen, Mario
    Van der Maarel, Silvere M.
    Burden, Steven J.
    Verschuuren, Jan J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (51) : 20783 - 20788
  • [26] Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice
    Ulusoy, Canan
    Cavus, Filiz
    Yilmaz, Vuslat
    Tuzun, Erdem
    IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (05) : 490 - 499
  • [27] Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis
    Romi, Fredrik
    Suzuki, Shigeaki
    Suzuki, Norihiro
    Petzold, Axel
    Plant, Gordon T.
    Gilhus, Nils Erik
    JOURNAL OF NEUROLOGY, 2012, 259 (07) : 1312 - 1316
  • [28] Anti-acetylcholine receptor antibodies: effect of immunosuppressive drug therapy in patients with myasthenia gravis
    Sidnev, D. V.
    Sanadze, A. G.
    Dedaev, S. I.
    Karganov, M. Yu.
    Alchinova, I. B.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (11) : 37 - 40
  • [29] Clinical analysis of Chinese anti-low-density-lipoprotein-receptor-associated protein 4 antibodies in patients with myasthenia gravis
    Li, M.
    Han, J.
    Zhang, Y.
    Lv, J.
    Zhang, J.
    Zhao, X.
    Ren, L.
    Fang, H.
    Yang, J.
    Zhang, Y.
    Cui, X.
    Zhang, Q.
    Li, Q.
    Du, Y.
    Gao, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (10) : 1296 - +
  • [30] An update of the pharmacological treatment options for generalized myasthenia gravis in adults with anti-acetylcholine receptor antibodies
    Riley, Tanya R.
    Douglas, Janine S.
    Wang, Christopher
    Bowser, Kiarra M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (11) : 652 - 662
12345